Es. Ganotakis et al., PRELIMINARY-REPORT - CIPROFIBRATE-FLUVASTATIN COMBINATION THERAPY FORDYSLIPIDEMIA, Journal of drug development and clinical practice, 8(3), 1996, pp. 171-175
Correcting abnormalities in the lipid profile is beneficial in reducin
g the risk of myocardial infarction. Recent studies indicate an enhanc
ed effect using a combination of a statin and a fibrate. This prelimin
ary report describes four cases where improved lipid profile and serum
fibrinogen levels were found following combined therapy with ciprofib
rate and fluvastatin. Further studies appear to be warranted.